CompoAtlas

Rub A535 Arthritis Cream

Natural health product licensed in Canada

Licence holder
Church & Dwight Canada Corp.
NPN or DIN-HM
02241872
Status
Inactive licence
Licence date
10 August 2009
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Capsaïcine

Source : Capsicum annuum

0.05 % (p/p)

Non-medicinal ingredients

Eau purifiée, Stéarate de PEG-75, propylèneglycol, Alcool cétylique, Sulfate de chondroïtine de sodium, diazolidinyl urée, Acétate de dl-alpha tocophéryle, Aloe Barbadensis Leaf Extract, Parahydroxybenzoate de méthyle, Stéarate de glycéryle, Lactate de menthyle, Gomme de xanthane, Calcium Disodium EDTA, (p)-hydroxybenzoate de propyle, Glycérine, Acide citrique, Phosphate de sodium, dibasique, Huile minérale légère, Lanoline, Hydroxytoluene butylé

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedNot specifiedminimum: 3 Tous les jours ; maximum: 4 Tous les jours
Enfantsminimum: 12 yearsNot specifiedminimum: 3 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Indicated for temporary relief of muscle and joint pain associated with rheumatoid arthritis and osteoarthritis, backache, lumbago, strains and sprains, pain or tendons and ligaments.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 02241872

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line